5,370 followers
Current ToC: EGFR-Mutant Lung Adenocarcinomas Treated First-Line with the Novel EGFR Inhibitor, XL647, Can Subse... http://t.co/cMoXQ38C
EGFR-Mutant Lung Adenocarcinomas Treated First-Line with the Novel EGFR Inhibitor, XL647, Can Subsequently Retain Moderate Sensitivity to Erlotinib
Overview of attention for article published in Journal of Thoracic Oncology, February 2012
Altmetric Badge
About this Attention Score
-
Good Attention Score compared to outputs of the same age (71st percentile)
-
Good Attention Score compared to outputs of the same age and source (75th percentile)
Readers on
- mendeley
- 32 Mendeley